Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc.
CSE Index:
CSE CompositeCurrency:
CAD Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of the Substituted methylenedioxy- phenethylamines class (“MDXX”), including 3,4-Methylenedioxymethamphetamine (“MDMA”). Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug delivery pathways for these molecules.
Pharmala Biotech Holdings Inc. (MDMA)
0.155
-0.005 (-3.13%)
Pharmala Biotech Holdings Inc. (MDMA)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
39,000
Bid Price
0.155
Ask Price
0.16
Ask Size
28,500
Volume
101,049
Last Price
0.155
Tick
Net Change
-0.005
Prev Close
0.16
Open
0.155
Day High
0.16
Day Low
0.155
52 Week High
0.34
52 Week Low
0.065
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.30
Tick
Net Change
Prev Close
0.30
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
39,000
Bid Price
0.155
Ask Price
0.16
Ask Size
28,500
Volume
101,049
Last Price
0.155
Tick
Net Change
-0.005
Prev Close
0.16
Open
0.155
Day High
0.16
Day Low
0.155
52 Week High
0.34
52 Week Low
0.065
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.30
Tick
Net Change
Prev Close
0.30
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| CIBC World Markets Inc. | 30,500 | 0.155 | 0.16 | 5,500 | Desjardins Securities Inc. |
| National Bank Financial Inc. | 5,500 | 0.155 | 0.16 | 7,500 | RBC Capital Markets |
| Desjardins Securities Inc. | 3,000 | 0.155 | 0.16 | 15,500 | RBC Capital Markets |
| Desjardins Securities Inc. | 2,000 | 0.15 | 0.165 | 6,000 | Desjardins Securities Inc. |
| National Bank Financial Inc. | 10,000 | 0.15 | 0.17 | 14,000 | Scotia Capital Inc. |
| TD Securities Inc. | 39,000 | 0.15 | 0.17 | 17,000 | RBC Capital Markets |
| TD Securities Inc. | 40,000 | 0.15 | 0.175 | 5,000 | BMO Nesbitt Burns Inc. |
| TD Securities Inc. | 12,000 | 0.15 | 0.175 | 62,500 | TD Securities Inc. |
| BMO Nesbitt Burns Inc. | 5,000 | 0.14 | 0.18 | 10,000 | BMO Nesbitt Burns Inc. |
| National Bank Financial Inc. | 2,000 | 0.14 | 0.18 | 500 | Virtu Canada Corp. |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 3 | 39,000 | 0.155 | 0.16 | 28,500 | 3 |
| 5 | 103,000 | 0.15 | 0.165 | 6,000 | 1 |
| 2 | 7,000 | 0.14 | 0.17 | 31,000 | 2 |
| 1 | 500 | 0.135 | 0.175 | 67,500 | 2 |
| 1 | 7,500 | 0.13 | 0.18 | 10,500 | 2 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 21, 18:10 | 0.155 | 0.00 | 47,000 | CIBC World Markets Inc. | Anonymous | CSE |
| Apr 21, 18:07 | 0.155 | 0.00 | 4,500 | Desjardins Securities Inc. | Desjardins Securities Inc. | CSE |
| Apr 21, 18:07 | 0.155 | 0.00 | 36,500 | CIBC World Markets Inc. | Desjardins Securities Inc. | CSE |
| Apr 21, 17:47 | 0.16 | 0.005 | 3,000 | CIBC World Markets Inc. | Desjardins Securities Inc. | CSE |
| Apr 21, 17:47 | 0.16 | 0.005 | 2,500 | CIBC World Markets Inc. | Desjardins Securities Inc. | CSE |
Company Info
Address
82 Richmond St.
Toronto, ON M5C 1P1
CanadaPhone
1-855-444-6362Email
outreach@pharmala.caWebsite
https://pharmala.ca/Listing date
Tuesday, January 11, 2022Transfer Agent
Marrelli Trust Company LimitedEmail
investors@pharmala.caAuditor
Clearhouse LLPSEDAR Information
Filing Type
Any
Material Change Report
News Releases
Financial Statements
Management's Discussion & Analysis
Timeframe
1 week1 month3 month6 month1 yearAll Time
Pharmala Biotech Holdings Inc.
Date:
Dec 30, 2024
Pharmala Biotech Holdings Inc.
Date:
Dec 20, 2024
Pharmala Biotech Holdings Inc.
Date:
Dec 20, 2024
Pharmala Biotech Holdings Inc.
Date:
Dec 20, 2024
Pharmala Biotech Holdings Inc.
Date:
Jul 29, 2024
Pharmala Biotech Holdings Inc.
Date:
Jul 29, 2024
Pharmala Biotech Holdings Inc.
Date:
Apr 29, 2024
Pharmala Biotech Holdings Inc.
Date:
Apr 29, 2024
Pharmala Biotech Holdings Inc.
Date:
Apr 29, 2024
Pharmala Biotech Holdings Inc.
Date:
Jan 29, 2024
Pharmala Biotech Holdings Inc.
Date:
Jan 29, 2024
Pharmala Biotech Holdings Inc.
Date:
Dec 29, 2023
Pharmala Biotech Holdings Inc.
Date:
Dec 29, 2023
Pharmala Biotech Holdings Inc.
Date:
Dec 29, 2023
Pharmala Biotech Holdings Inc.
Date:
Jul 31, 2023
Pharmala Biotech Holdings Inc.
Date:
Jul 31, 2023
Pharmala Biotech Holdings Inc.
Date:
May 1, 2023
Pharmala Biotech Holdings Inc.
Date:
May 1, 2023
Pharmala Biotech Holdings Inc.
Date:
Jan 30, 2023
Pharmala Biotech Holdings Inc.
Date:
Jan 30, 2023
Pharmala Biotech Holdings Inc.
Date:
Dec 23, 2022
Pharmala Biotech Holdings Inc.
Date:
Dec 23, 2022
Pharmala Biotech Holdings Inc.
Date:
Dec 23, 2022
Pharmala Biotech Holdings Inc.
Date:
Jul 29, 2022
Pharmala Biotech Holdings Inc.
Date:
Jul 29, 2022
Pharmala Biotech Holdings Inc.
Date:
Apr 29, 2022
Pharmala Biotech Holdings Inc.
Date:
Apr 29, 2022
Pharmala Biotech Holdings Inc.
Date:
Jan 24, 2022
Pharmala Biotech Holdings Inc.
Date:
Jan 24, 2022
Pharmala Biotech Holdings Inc.
Date:
Dec 21, 2021
Pharmala Biotech Holdings Inc.
Date:
Nov 26, 2021
Pharmala Biotech Holdings Inc.
Date:
May 25, 2021
Pharmala Biotech Holdings Inc.
Date:
Feb 16, 2021
Pharmala Biotech Holdings Inc.
Date:
Jan 21, 2021
Company Info
Address
82 Richmond St.
Toronto, ON M5C 1P1
CanadaPhone
1-855-444-6362Email
outreach@pharmala.caWebsite
https://pharmala.ca/Listing date
Tuesday, January 11, 2022Transfer Agent
Marrelli Trust Company LimitedEmail
investors@pharmala.caAuditor
Clearhouse LLPCapitalization
Issued & Outstanding:
103344583Reserved for Issuance:
20627066Company Officers
Nicholas Kadysh , President, Chief Executive Officer and Director
Shane Morris , Chief Operating Officer
Will Avery, Chief Financial Officer
Bulletins
10/01/2022
2022-0110 - New Listing - Pharmala Biotech Holdings Inc. (MDMA)
le 10 janvier/January 2022
The common shares of Pharmala Biotech Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
